Stories
Prime maintains CEO Cancer Gold Standard designation
Accreditation from CEO Roundtable on Cancer continues since 2012
February 17, 2021Business leaders know cancer affects their workforces, and research confirms cancer’s impact on American workers and their families. But more than half of all cancer deaths can be prevented through early diagnosis.
“Employers report a level of complexity in managing employees’ cancer-related needs beyond that associated with any other type of disease or condition.”
– Northeast Business Group on Health (NEBGH) Cancer and the Workplace: The Employer Perspective report¹
Since 2012, Prime Therapeutics has joined more than 200 companies that are recognized as a CEO Cancer Gold Standard™ organization for their efforts to reduce cancer among its employees. By focusing on cancer risk reduction, early detection, and quality care, the program can help save employee lives.
To earn Gold Standard accreditation, Prime established programs that reduce cancer risk by taking concrete actions in five key areas:
- Emphasize prevention by prohibiting tobacco use and supporting tobacco cessation efforts
- Promote healthy lifestyles through physical activity, healthy nutrition and weight management
- Provide health insurance options that encourage detection of cancer at its earliest stages, ensure access to quality care, and allow participation in cancer clinical trials
- Promote employee awareness of these initiatives, and
- Support the needs of cancer survivors in the workplace.
Prime’s employees are its greatest resource. By following the Gold Standard program and supporting healthy behaviors, the company is having a positive impact on them, their families and their communities.
- Northeast Business Group on Health. (2015, October). Cancer and the Workplace: The Employer Perspective. https://nebgh.org/wp-content/uploads/2015/10/CancerWorkplace_FINAL.pdf
Related news
Stories
April 24, 2024
New study conducted by Prime Therapeutics researchers offers insights into ways to increase equity in health care
Research published in the Journal of Managed Care & Specialty Pharmacy uses population data to fill gaps in social determinants of health data, providing a more complete understanding of a patient’s global health circumstances
Stories
April 5, 2024
LISTEN NOW: Revolutionizing Healthcare: Prime & Capital Rx’s Game-Changing Alliance – Pharmacy Friends podcast
In this special episode of the Pharmacy Friends podcast, the CEOs of Prime Therapeutics, Mostafa Kamal, and Capital Rx, AJ Loiacono, join Michael Passanante, SVP of Marketing & Communications at Capital Rx, to share the story behind the strategic alliance between the organizations and their vision to reimagine pharmacy.
Stories
March 26, 2024
Announcing the new issue of Prime’s managed care report, featuring the latest trends and updates in medical and pharmacy benefits
Prime Therapeutics/Magellan Rx (Prime/MRx) today launched the spring edition of Magellan Rx Report…